Companies
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
IMF Criticises MENA Business Environment
January 2007 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
The International Monetary Fund (IMF) has criticised countries in the Middle East and North Africa (MENA) region for having institutional weaknesses that deter foreign direct investment (FDI). These include cumbersome and costly business procedures and poor regulatory systems, which have a detrimental effect on industries such as pharmaceuticals.